Cancer Research AACR Legacy  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tinley, T. L.
Right arrow Articles by Mooberry, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tinley, T. L.
Right arrow Articles by Mooberry, S. L.
[Cancer Research 63, 3211-3220, June 15, 2003]
© 2003 American Association for Cancer Research


Experimental Therapeutics

Taccalonolides E and A

Plant-derived Steroids with Microtubule-stabilizing Activity1

Tina L. Tinley, Deborah A. Randall-Hlubek, Rachel M. Leal, Evelyn M. Jackson, James W. Cessac, James C. Quada, Jr.2, Thomas K. Hemscheidt and Susan L. Mooberry3

Departments of Physiology and Medicine [T. L. T., D. A. R-H., R. M. L., E. M. J., J. C. Q., S. L. M.] and Organic Chemistry [J. W. C.], Southwest Foundation for Biomedical Research, San Antonio, Texas 78227, and Department of Chemistry, University of Hawaii, Honolulu, Hawaii 96822 [T. K. H.]

During the course of a mechanism-based screening program designed to identify new microtubule-disrupting agents from natural products, we identified a crude extract from Tacca chantrieri that initiated Taxol-like microtubule bundling. Bioassay-directed purification of the extract yielded the highly oxygenated steroids taccalonolides E and A. The taccalonolides caused an increased density of cellular microtubules in interphase cells and the formation of thick bundles of microtubules similar to the effects of Taxol. Mitotic cells exhibited abnormal mitotic spindles containing three or more spindle poles. The taccalonolides were evaluated for antiproliferative effects in drug-sensitive and multidrug-resistant cell lines. The data indicate that taccalonolide E is slightly more potent than taccalonolide A in drug-sensitive cell lines and that both taccalonolides are effective inhibitors of cell proliferation. Both taccalonolides are poorer substrates for transport by P-glycoprotein than Taxol. The ability of the taccalonolides to circumvent mutations in the Taxol-binding region of ß-tubulin was examined using the PTX 10, PTX 22, and 1A9/A8 cell lines. The data suggest little cross-resistance of taccalonolide A as compared with Taxol, however, the data from the PTX 22 cell line indicate a 12-fold resistance to taccalonolide E, suggesting a potential overlap of binding sites. Characteristic of agents that disrupt microtubules, the taccalonolides caused G2-M accumulation, Bcl-2 phosphorylation, and initiation of apoptosis. The taccalonolides represent a novel class of plant-derived microtubule-stabilizers that differ structurally and biologically from other classes of microtubule-stabilizers.




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. L. Risinger, E. M. Jackson, L. A. Polin, G. L. Helms, D. A. LeBoeuf, P. A. Joe, E. Hopper-Borge, R. F. Luduena, G. D. Kruh, and S. L. Mooberry
The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
Cancer Res., November 1, 2008; 68(21): 8881 - 8888.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. F. Beyer, N. Zhang, R. Hernandez, D. Vitale, J. Lucas, T. Nguyen, C. Discafani, S. Ayral-Kaloustian, and J. J. Gibbons
TTI-237: A Novel Microtubule-Active Compound with In vivo Antitumor Activity
Cancer Res., April 1, 2008; 68(7): 2292 - 2300.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. L. Mooberry, K. N. Weiderhold, S. Dakshanamurthy, E. Hamel, E. J. Banner, A. Kharlamova, J. Hempel, J. T. Gupton, and M. L. Brown
Identification and Characterization of a New Tubulin-Binding Tetrasubstituted Brominated Pyrrole
Mol. Pharmacol., July 1, 2007; 72(1): 132 - 140.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Hamel, B. W. Day, J. H. Miller, M. K. Jung, P. T. Northcote, A. K. Ghosh, D. P. Curran, M. Cushman, K. C. Nicolaou, I. Paterson, et al.
Synergistic Effects of Peloruside A and Laulimalide with Taxoid Site Drugs, but Not with Each Other, on Tubulin Assembly
Mol. Pharmacol., November 1, 2006; 70(5): 1555 - 1564.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. L. Mooberry, D. A. Randall-Hlubek, R. M. Leal, S. G. Hegde, R. D. Hubbard, L. Zhang, and P. A. Wender
From the Cover: Microtubule-stabilizing agents based on designed laulimalide analogues
PNAS, June 8, 2004; 101(23): 8803 - 8808.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.